BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29949733)

  • 1. Neuropeptide modulation of addiction: Focus on galanin.
    Genders SG; Scheller KJ; Djouma E
    Neurosci Biobehav Rev; 2020 Mar; 110():133-149. PubMed ID: 29949733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neuropeptide-centric view of psychostimulant addiction.
    Boutrel B
    Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The affective dimension of pain as a risk factor for drug and alcohol addiction.
    LeBlanc DM; McGinn MA; Itoga CA; Edwards S
    Alcohol; 2015 Dec; 49(8):803-9. PubMed ID: 26008713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic neuropeptide signaling in alcohol addiction.
    Barson JR; Leibowitz SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():321-9. PubMed ID: 25689818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission.
    Cannella N; Kallupi M; Ruggeri B; Ciccocioppo R; Ubaldi M
    Prog Neurobiol; 2013 Jan; 100():48-59. PubMed ID: 23041581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin and addiction.
    Picciotto MR
    Exp Suppl; 2010; 102():195-208. PubMed ID: 21299070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of endogenous neuropeptides in the pathomechanism of alcohol addiction].
    Rudzińska U; Zalewska-Kaszubska J
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():643-52. PubMed ID: 20097951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides in learning and memory processes with focus on galanin.
    Ogren SO; Kuteeva E; Elvander-Tottie E; Hökfelt T
    Eur J Pharmacol; 2010 Jan; 626(1):9-17. PubMed ID: 19837050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.
    Schank JR; Ryabinin AE; Giardino WJ; Ciccocioppo R; Heilig M
    Neuron; 2012 Oct; 76(1):192-208. PubMed ID: 23040815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective roles for the PC2 processing enzyme in the regulation of peptide neurotransmitter levels in brain and peripheral neuroendocrine tissues of PC2 deficient mice.
    Miller R; Toneff T; Vishnuvardhan D; Beinfeld M; Hook VY
    Neuropeptides; 2003 Jun; 37(3):140-8. PubMed ID: 12860111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neuropeptides in suicidal behavior: a systematic review.
    Serafini G; Pompili M; Lindqvist D; Dwivedi Y; Girardi P
    Biomed Res Int; 2013; 2013():687575. PubMed ID: 23986909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropeptides Galanin and Galanin(1-15) in depression-like behaviours.
    Millón C; Flores-Burgess A; Narváez M; Borroto-Escuela DO; Gago B; Santín L; Castilla-Ortega E; Narváez JÁ; Fuxe K; Díaz-Cabiale Z
    Neuropeptides; 2017 Aug; 64():39-45. PubMed ID: 28196617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
    Heilig M
    J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholism and neuropeptides: an update.
    Cowen MS; Lawrence AJ
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):233-9. PubMed ID: 16611096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
    Valdez GR; Koob GF
    Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin and addiction.
    Picciotto MR
    Cell Mol Life Sci; 2008 Jun; 65(12):1872-9. PubMed ID: 18500649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.
    Roberto M; Spierling SR; Kirson D; Zorrilla EP
    Int Rev Neurobiol; 2017; 136():5-51. PubMed ID: 29056155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.